Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors' Dealings notification transmitted by DGAP - a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Details of the person subject to the disclosure requirement Last name: Dr. Schüttrumpf First name: Jörg Company: Biotest AG Position: Senior Vice President Global Research Information about the transaction with duty of notification Description of the financial instrument: Preference Shares ISIN/WKN of the financial instrument: DE00052272235 Type of transaction: Purchase Date: 21.05.2013 Price: 56.00 Currency: EUR No. of items: 750 Total amount traded: 42000.00 Place: Stuttgart Information about the company with duty of publication Issuer: Biotest AG LandsteinerstraÃe 5 63303 Dreieich Deutschland ISIN: DE0005227235 WKN: 522723 End of Directors' Dealings Notification (c) DGAP 22.05.2013 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de ID 16983
DGAP-DD: Biotest AG english
| Source: EQS Group AG